How to get peptides prescribed online, legally

To get peptides prescribed online legally, you complete a telehealth assessment, a clinician licensed in your state decides whether to prescribe, and a licensed US pharmacy compounds the drug for you by name. Sermorelin, NAD+ and glutathione are prescribable today, from $94 a month for sermorelin; six more peptides fall under an interim HHS policy. None is FDA-approved in compounded form.

This guide covers the steps, which peptides a clinician can and cannot prescribe as of October 30, 2026, how to check a program before you pay, and the red flags that separate a prescription program from a website selling vials. Prices are on our live price table.

The steps, from assessment to your door

1. Pick the peptide, then check its status. The legal route depends on the peptide (see the table below). If a program offers something with no route, stop there.
2. Online assessment. You fill in goals, health history and current medications. Some programs add a video or phone visit; many are asynchronous (a clinician reads your answers later).
3. Clinician review. A physician, nurse practitioner or physician assistant licensed in your state decides whether to prescribe. A good program will sometimes say no. Dose is set here, by the prescriber, and we do not cover dosing on this site.
4. Labs, where offered. Some programs include a blood panel and repeat labs. Superpower's peptide page lists "CBC/CMP monitoring every six months while treatment continues" (Superpower). Most sermorelin programs we track do not include labs; Hone Health does, through its membership.
5. Pharmacy. The prescription goes to a compounding pharmacy that makes the drug for you as a named patient. For the six peptides under the HHS policy, that must be a 503A pharmacy (503B outsourcing facilities are not covered).
6. Shipping and follow-up. The pharmacy ships to you with a label that names you, the prescriber and the pharmacy. Check-ins and refills run through the program.

The whole process is a prescription, not a purchase. If any step is missing, especially the clinician or the named pharmacy, it is not a prescription program.

What a US clinician can prescribe in 2026

Prices come from each program's own page; the price table links every figure to its source and the date we read it. A peptide with several programs has its own page, for example sermorelin prices and BPC-157 prices.

Category 1: NAD+, glutathione, topical GHK-Cu

FDA keeps a list of bulk substances nominated for 503A compounding. Category 1 is "Bulk Drug Substances Under Evaluation" (FDA, updated May 14, 2026). FDA's 503A page says it "does not intend to take action against a compounder for compounding drugs using bulk drug substances listed in category 1, provided that the conditions described in the guidance document are met" (FDA). NAD, glutathione and non-injectable GHK-Cu are on that list as of its May 14, 2026 update.

The six peptides under the HHS interim policy

On October 28, 2026 HHS filed a notice, published October 30, saying it "does not intend to take enforcement action against a State-licensed pharmacy, Federal facility, or licensed physician compounding a drug product using a peptide bulk drug substance found in Appendix A" (Federal Register). Appendix A names BPC-157, TB-500, MOTS-c, Semax, Epitalon and KPV, each in set forms and routes, as single ingredients only (AJMC summary; the HHS appendix itself blocked our reader on October 30, 2026).

Three limits matter for buyers. The policy is interim: HHS "may revisit application of this interim policy (in whole or in part) if, among other things, a safety signal or product quality issue arises" (Federal Register). It does not cover blends or 503B facilities. And it does not bind state pharmacy boards. Compounded drugs are not FDA-approved; we checked the policy on October 30, 2026. Our HHS peptide policy guide and peptide legal status tracker go through the details.

What is not prescribable through these routes

Peptides outside both lists have no compounding route that we can find. CJC-1295 and ipamorelin, for example, are not named in the HHS policy and do not appear in any of the three categories on FDA's May 14, 2026 list. Ibutamoren and kisspeptin-10 are in Category 2, "Bulk Drug Substances that Raise Significant Safety Risks" (FDA). Blends of two or more peptides, such as BPC-157 with TB-500, are outside the HHS policy. A program selling any of these is taking a legal risk you share.

How to check a program before you pay

Four checks, all free:

• A named pharmacy. Ask which pharmacy compounds your peptide and whether it is 503A. Then look the pharmacy up in your state board's database. FDA keeps a list of state lookups and advises: "If your online pharmacy is not listed, you should not use that pharmacy." (FDA BeSafeRx)
• LegitScript. LegitScript certifies telehealth and pharmacy websites. Search the program's domain on LegitScript's lookup. Superpower, for one, states "Superpower is LegitScript certified" (Superpower FAQ); the lookup uses a reCAPTCHA, so confirm it by hand.
• State coverage and licensing. The clinician must be licensed where you live. Programs that publish a state list are easier to trust; several we track do not. Our state pages show what each program says.
• FDA warning letters. Search the company name in FDA's warning-letter database. Read any letter you find: it may concern an unrelated product, and many are resolved. We run this check on every program we list.

Red flags

• No prescription, no clinician. Any site that sells you a peptide with a checkout and no medical review is not a prescription program.
• "Research use only" labels. FDA has rejected this label in warning letters to peptide sellers, writing that "evidence obtained from your website establishes that your products are intended to be drugs for human use" (FDA warning letter, August 2026). We do not list these sellers. Our guide to research vs prescription peptides explains the difference.
• Calling a compounded peptide FDA-approved. The Federal Register notice says plainly that compounded drugs "are not FDA-approved" (Federal Register).
• Blends and stacks of the six peptides, which the HHS policy does not cover.
• No pharmacy name, no state list and no cancellation terms. One missing is common; all three missing is a reason to look elsewhere.
• Dose tables or mixing instructions on the sales page. A prescription program leaves dose to the prescriber and the pharmacy label.

For more on pharmacy quality, see compounded peptide safety.

What it costs

You pay cash. None of the programs we track says it bills insurance for these peptides, because compounded drugs are not FDA-approved products. Today's floor across every program and peptide is $57 a month (Idun Rx). The lowest monthly rates usually need a 6- or 12-month prepayment, and many programs refund nothing once you submit an intake. Compare the month-to-month price first; our sermorelin cost guide and BPC-157 cost guide walk through the fees.

FAQ

How do I get peptides prescribed online, legally?

Choose a telehealth program that uses a clinician licensed in your state and a named, licensed US pharmacy. Complete its assessment, and if the clinician prescribes, the pharmacy compounds the peptide for you by name and ships it. Check that the peptide has a legal compounding route first: sermorelin, NAD+ and glutathione do, and six more fall under the interim HHS policy.

Can I get a peptide prescription online without seeing a doctor in person?

Yes. Most peptide programs run the visit online, often as a questionnaire a clinician reviews later, sometimes with a video call. The clinician still has to be licensed in your state, and may decline to prescribe. Some programs add lab work before or during treatment.

What is peptide telehealth?

Peptide telehealth is an online program where a licensed clinician reviews your health history and, where appropriate, prescribes a compounded peptide that a licensed pharmacy makes for you. Prices usually include the consult, the drug and shipping. It differs from research-use-only websites, which skip the clinician and the pharmacy entirely.

Which peptides can be prescribed online in 2026?

Sermorelin, NAD+, glutathione and topical GHK-Cu have established compounding routes. BPC-157, TB-500, MOTS-c, Semax, Epitalon and KPV can be compounded by 503A pharmacies under the interim HHS policy of October 28, 2026, as single ingredients in set forms. Compounded versions are not FDA-approved, and the HHS policy can be withdrawn. Checked October 30, 2026.

Are online peptide prescriptions covered by insurance?

Not at the programs we track. Compounded peptides are not FDA-approved, so insurers rarely cover them. Some programs say their fees may be HSA or FSA eligible; ask the program for an itemized receipt and check with your plan.

How can I tell if a peptide website is legitimate?

Look for a clinician review, a named pharmacy you can find in your state board's database, published state coverage and cancellation terms, and LegitScript certification. Search FDA's warning-letter database for the company name. Walk away from "research use only" labels, sites with no prescription step, and any claim that a compounded peptide is FDA-approved.

Compare every licensed program on our peptide price table, or start with our ranked best peptide programs.